Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Marshall Island Business Digest.
Press releases published on April 24, 2025
Century Aluminum Sets Date for First Quarter 2025 Earnings Announcement
GlobeNewswire
·
April 24, 2025
CHICAGO, April 24, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) will report first quarter 2025 earnings on Wednesday, May 7, 2025, after market close. The news release will be issued through GlobeNewswire. The company will hold a follow …
AppFolio, Inc. Announces First Quarter 2025 Financial Results
GlobeNewswire
·
April 24, 2025
SANTA BARBARA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- AppFolio, Inc. (NASDAQ: APPF) ("AppFolio" or the "Company"), a technology leader powering the future of the real estate industry, today announced its financial results for the first quarter ended …
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
GlobeNewswire
·
April 24, 2025
Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation …
Ottawa Bancorp, Inc. Announces 2025 First Quarter Results and Approval of Stock Repurchase Program
GlobeNewswire
·
April 24, 2025
OTTAWA, Ill., April 24, 2025 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for OSB Community Bank (the “Bank”), announced net income of $0.4 million, or $0.19 per basic and diluted common share, for the three …
Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor
GlobeNewswire
·
April 24, 2025
► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis ► The biomarker signatures developed for fibrosis improvement, MASH resolution and composite histological …
Inventiva annonce la publication dans Clinical Gastroenterology and Hepatology de l’analyse de nouvelles signatures de biomarqueurs prédictives de la réponse histologique chez les patients atteints de MASH traités par lanifibranor
GlobeNewswire
·
April 24, 2025
► Des signatures de biomarqueurs ont été développées pour prédire la réponse histologique au traitement par lanifibranor chez les patients atteints de MASH avec fibrose ► Les signatures de biomarqueurs développées pour l’amélioration de la fibrose, la …
Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025
GlobeNewswire
·
April 24, 2025
LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 29, 2025 at 8:30 a.m. Eastern Time to report its first quarter 2025 …
Business First Bancshares, Inc., Announces Financial Results for Q1 2025
GlobeNewswire
·
April 24, 2025
BATON ROUGE, La., April 24, 2025 (GLOBE NEWSWIRE) -- Business First Bancshares, Inc. (NASDAQ: BFST) (Business First), parent company of b1BANK, today announced its unaudited results for the quarter ended March 31, 2025. Business First reported net income …
IBTA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ibotta, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk
GlobeNewswire
·
April 24, 2025
Interpace Expects to Remain Profitable as a Thyroid-focused Business PARSIPPANY, NJ, April 24, 2025 (GLOBE NEWSWIRE) -- Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that the …
EverCommerce Announces Date of First Quarter 2025 Earnings Call
GlobeNewswire
·
April 24, 2025
DENVER, April 24, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, will report its first quarter 2025 financial results after the U.S. financial markets close on Thursday, May 8, 2025. …
BayFirst Financial Corp. Reports First Quarter 2025 Results
GlobeNewswire
·
April 24, 2025
ST. PETERSBURG, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- BayFirst Financial Corp. (NASDAQ: BAFN) (“BayFirst” or the “Company”), parent company of BayFirst National Bank (the “Bank”) today reported a net loss of $0.3 million, or $0.17 per common share and …
Lottery Defeated Under Review: How to Become a True Lotto Defeater & Win Big with LottoCash AI
GlobeNewswire
·
April 24, 2025
New York City, April 24, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: How Lottery Defeated transforms traditional lottery play into a data-informed strategy Why LottoCash AI uses decades of draw history to generate statistically optimized …
Golden Sky Minerals Announces Investment from Canadian Mining Leader Rob McEwen
GlobeNewswire
·
April 24, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- Golden Sky Minerals Corp. (TSX-V: AUEN) (“Golden Sky” or the “Company”) is pleased to …
Bitfarms Ltd. Announcement: If You Have Suffered Losses in Bitfarms Ltd. (NASDAQ: BITF), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Bitfarms Ltd. (NASDAQ: BITF) resulting from allegations that Bitfarms may …
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages TFI International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TFII
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TFI International Inc. (NYSE: TFII) between April 26, 2024 and February 19, 2025, both dates inclusive (the “Class …
Undergraduate Musicians Encouraged to Apply for Dr. James Morales Music Education Scholarship
GlobeNewswire
·
April 24, 2025
HOWELL, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- The Dr. James Morales Award for Music Education is now officially open for applications, marking a significant initiative dedicated to supporting undergraduate students across the United States who are …
TIAA CEO Thasunda Brown Duckett to Headline the INROADS 2025 Benefit Gala
GlobeNewswire
·
April 24, 2025
ATLANTA, GA, April 24, 2025 (GLOBE NEWSWIRE) -- INROADS is honored to announce that Thasunda Brown Duckett, President and CEO of TIAA and renowned INROADS alumna, will deliver inspirational remarks during its 2025 Benefit Gala presented by P…
HQY Announcement: If You Have Suffered Losses in HealthEquity, Inc. (NASDAQ: HQY) You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from allegations that …
Cohen Milstein Seeks Investors Willing to Lead Zenas BioPharma (ZBIO) Securities Fraud Class Action
GlobeNewswire
·
April 24, 2025
WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- Investors in Zenas BioPharma, Inc. (NASDAQ: ZBIO) who bought shares in the company’s September 2024 IPO may be eligible to participate in and lead a class action lawsuit now pending in federal court. Cohen …